RT @acmoorephd: Studies like this, showing the efficacy of targeted therapy in the neoadj setting in a patient with RET+ resectable NSCLC,…
0 followers
6,531 followers
New research: Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer: The LIBRETTO-001 trial demonstrated the activity of the selective… #oncology https
1,119 followers
RT @acmoorephd: Studies like this, showing the efficacy of targeted therapy in the neoadj setting in a patient with RET+ resectable NSCLC,…
289 followers
RT @acmoorephd: Studies like this, showing the efficacy of targeted therapy in the neoadj setting in a patient with RET+ resectable NSCLC,…